Klaria Annual Report 2022 - Börskollen
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Pressmeddelande

Klaria Annual Report 2022

The year in brief

- Net sales amounted to 5.9 MSEK (0.0 MSEK)

- Other operating income amounted to 0.7 MSEK (37.5 MSEK)

- R&D costs amounted to 51.4 MSEK (63.5 MSEK)

- Profit/loss after tax amounted to -63.8 MSEK (-53.5 MSEK)

- Earnings per share amounted to -1.10 SEK (-1.03 SEK)

- Cash flow from operations amounted to -49.7 MSEK (-24.8 MSEK)

- Shareholder’s equity as of December 31, 2022 amounted to 76.1 MSEK (69.4 MSEK)

- Cash and cash equivalents as of December 31, 2022 amounted to 16.8 MSEK (25.5 MSEK)

Bifogade filer

Nyheter om Klaria Pharma

Läses av andra just nu

Om aktien Klaria Pharma

Senaste nytt